相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma
Mark A. Dickson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Converting Cancer Therapies into Cures: Lessons from Infectious Diseases
Michael S. Glickman et al.
CELL (2012)
CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy
A. Kathleen McClendon et al.
CELL CYCLE (2012)
Dividing and conquering: controlling advanced melanoma by targeting oncogene-defined subsets
Keith T. Flaherty
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Copy Number Losses Define Subgroups of Dedifferentiated Liposarcoma with Poor Prognosis and Genomic Instability
Aimee M. Crago et al.
CLINICAL CANCER RESEARCH (2012)
Combinatorial drug therapy for cancer in the post-genomic era
Bissan Al-Lazikani et al.
NATURE BIOTECHNOLOGY (2012)
Principles and Strategies for Developing Network Models in Cancer
Dana Pe'er et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma
Aimee M. Crago et al.
CURRENT OPINION IN ONCOLOGY (2011)
Acquired Radioresistance of Cancer and the AKT/GSK3β/cyclin D1 Overexpression Cycle
Tsutomu Shimura
JOURNAL OF RADIATION RESEARCH (2011)
Systematic exploration of synergistic drug pairs
Murat Cokol et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Pathway Commons, a web resource for biological pathway data
Ethan G. Cerami et al.
NUCLEIC ACIDS RESEARCH (2011)
Advances in sarcoma genomics and new therapeutic targets
Barry S. Taylor et al.
NATURE REVIEWS CANCER (2011)
Ligand-Specific c-Fos Expression Emerges from the Spatiotemporal Control of ErbB Network Dynamics
Takashi Nakakuki et al.
CELL (2010)
Chemical Probes of Escherichia coli Uncovered through Chemical-Chemical Interaction Profiling with Compounds of Known Biological Activity
Maya A. Farha et al.
CHEMISTRY & BIOLOGY (2010)
Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer
Kimberly L. Blackwell et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Proof of Concept: Network and Systems Biology Approaches Aid in the Discovery of Potent Anticancer Drug Combinations
Asfar S. Azmi et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Pairwise agonist scanning predicts cellular signaling responses to combinatorial stimuli
Manash S. Chatterjee et al.
NATURE BIOTECHNOLOGY (2010)
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Jordi Barretina et al.
NATURE GENETICS (2010)
Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II
Tanja Schneider et al.
SCIENCE (2010)
Resistance to Trastuzumab in Breast Cancer
Paula R. Pohlmann et al.
CLINICAL CANCER RESEARCH (2009)
Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model
Rashmi Chugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
Robert G. Maki et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Joseph Lehar et al.
NATURE BIOTECHNOLOGY (2009)
Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
Pasi A. Jaenne et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
SYSTEMS MICROBIOLOGY - OPINION Drug interactions and the evolution of antibiotic resistance
Pamela J. Yeh et al.
NATURE REVIEWS MICROBIOLOGY (2009)
PID: the Pathway Interaction Database
Carl F. Schaefer et al.
NUCLEIC ACIDS RESEARCH (2009)
Models from experiments: combinatorial drug perturbations of cancer cells
Sven Nelander et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
Combination chemical genetics
Joseph Lehar et al.
NATURE CHEMICAL BIOLOGY (2008)
Functional Copy-Number Alterations in Cancer
Barry S. Taylor et al.
PLOS ONE (2008)
Cooperative regulation of GSK-3 by muscarinic and PDGF receptors is associated with airway myocyte proliferation
Reinoud Gosens et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Endothelin-1, but not ang II, activates MAP kinases through c-Src - Independent ras-raf-dependent pathways in vascular smooth muscle cells
A. Yogi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Non-parametric quantification of protein lysate arrays
Jianhua Hu et al.
BIOINFORMATICS (2007)
Phase III trial of two Investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study
Paul Lorigan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma
Samuel Singer et al.
CANCER RESEARCH (2007)
High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections
Lixin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity
Wanping Xu et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Physicochemical modelling of cell signalling pathways
Bree B. Aldridge et al.
NATURE CELL BIOLOGY (2006)
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells
Raoul Tibes et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Systems biology and combination therapy in the quest for clinical efficacy
Jonathan B. Fitzgerald et al.
NATURE CHEMICAL BIOLOGY (2006)
Occupation of αvβ3-integrin by endogenous ligands modulates IGF-I receptor activation and proliferation of human intestinal smooth muscle
JF Kuemmerle
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity
Monica Fedele et al.
CANCER CELL (2006)
Functional classification of drugs by properties of their pairwise interactions
P Yeh et al.
NATURE GENETICS (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Differential sensitivity of liposarcoma subtypes to chemotherapy
RL Jones et al.
EUROPEAN JOURNAL OF CANCER (2005)
Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors
A Beeser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site
SM Ali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Causal protein-signaling networks derived from multiparameter single-cell data
K Sachs et al.
SCIENCE (2005)
EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis
C Vindis et al.
JOURNAL OF CELL BIOLOGY (2003)
Systematic discovery of multicomponent therapeutics
AA Borisy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Epidermal growth factor receptor: mechanisms of activation and signalling
RN Jorissen et al.
EXPERIMENTAL CELL RESEARCH (2003)
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
F Chang et al.
LEUKEMIA (2003)
Protein kinase C phosphorylates ribosomal protein S6 kinase βII and regulates its subcellular localization
T Valovka et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation
C Mur et al.
ENDOCRINOLOGY (2003)
Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen
MP Haynes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms
S Mohan et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B
MP Scheid et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
K Hara et al.
CELL (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Molecular crosstalk between p70S6k and MAPK cell signaling pathways
JA Lehman et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase - Critical roles for kinase activity and amino acids arginine 211 and serine 343
S Persad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
XJ Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Cell signaling by receptor tyrosine kinases
J Schlessinger
CELL (2000)
Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6
S Volarevic et al.
SCIENCE (2000)
Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors
T Hirano et al.
ONCOGENE (2000)
分享论文
